자료실 학회소개 학회소식 학술행사 분과전문의 자료실 학회지(JGO) 관련 사이트 최신 논문 가이드라인 Position Statement 보험 고시 사전신청요법 KSGO 회원 논문으로 보는 최신연구 최신 논문 부인암 수술동의서 부인암 수기
전체 전체 난소암 자궁경부암 자궁체부암 기타암 검색 제목 + 내용 작성자 검색 검색 초기화 총 게시글 : 177 Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial 2023-06-29 VIEW : 44 Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Updaterns 2023-06-29 VIEW : 19 Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer 2023-06-29 VIEW : 22 FIGO staging of endometrial cancer: 2023 2023-06-29 VIEW : 44 Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer 2023-06-29 VIEW : 22 Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer 2023-06-29 VIEW : 17 Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian Cancer 2023-06-29 VIEW : 29 High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors 2023-06-29 VIEW : 32 Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study 2023-06-29 VIEW : 14 Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts 2023-03-29 VIEW : 91 Preoperative brachytherapy for early-stage cervical cancer: Systematic review and meta-analysis 2023-03-29 VIEW : 38 Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial 2023-03-29 VIEW : 35 Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial 2023-03-29 VIEW : 34 Cancer Treatment-Related Ovarian Dysfunction in Women of Childbearing Potential: Management and Fertility Preservation Options 2023-03-29 VIEW : 47 NItrogen-based bisphosphonate use ad ovarian cancer risk in women aged 50 years and older 2022-10-13 VIEW : 87 1 2 3 4 5 6 7 8 9 10 11 12